National Insitute for Medical Research, Mwanza, Tanzania Report issue

Government

Organization Overview

First Clinical Trial
2006
NCT00347113
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

albendazole (Albenza) (1 trial)

praziquantel (biltricide) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2